Expertise in
10
conditions

Dr. Bruce C. Corser

Pulmonary Medicine | Sleep Medicine
Neurological And Sleep Disorders Inc
5240 E Galbraith Rd, Suite A, 
Cincinnati, OH 
Accepting New Patients
Offers Telehealth
Expertise in
10
conditions
Neurological And Sleep Disorders Inc
5240 E Galbraith Rd, Suite A, 
Cincinnati, OH 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Bruce Corser is a Pulmonary Medicine specialist and a Sleep Medicine provider in Cincinnati, Ohio. Dr. Corser is highly rated in 10 conditions, according to our data. His top areas of expertise are Narcolepsy, Drowsiness, Obstructive Sleep Apnea, and Excessive Daytime Sleepiness. Dr. Corser is currently accepting new patients.

His clinical research consists of co-authoring 9 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pulmonary Medicine
Sleep Medicine
Licenses
Sleep Medicine in OH
Hospital Affiliations
Christ Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Buckeye Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
CareFirst
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Essence Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Health Services
  • EPO
  • MANAGED MEDICAID PLAN
  • OTHER COMMERCIAL
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Mutual
  • HMO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

NEUROLOGICAL AND SLEEP DISORDERS INC
5240 E Galbraith Rd, Suite A, Cincinnati, OH 45236
Other Locations
NEUROLOGICAL AND SLEEP DISORDERS INC
4421 Eastgate Blvd, Suite 200, Cincinnati, OH 45245
NEUROLOGICAL AND SLEEP DISORDERS INC
2123 Auburn Ave, Suite 630, Cincinnati, OH 45219
NEUROLOGICAL AND SLEEP DISORDERS INC
20 Overbrook Dr, Suite F, Monroe, OH 45050
NEUROLOGICAL AND SLEEP DISORDERS INC
5885 Harrison Ave, Suite 3300, Cincinnati, OH 45248

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

Open Label Study of Safety/Tolerability of Once Nightly FT218 for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy Patients That Have and Have Not Been Previously Maintained on Twice-nightly Sodium Oxybate IR
Open Label Study of Safety/Tolerability of Once Nightly FT218 for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy Patients That Have and Have Not Been Previously Maintained on Twice-nightly Sodium Oxybate IR
Enrollment Status: Completed
Publish Date: October 02, 2025
Intervention Type: Drug
Study Phase: Phase 3
Adherence and Outcome of Upper Airway Stimulation (UAS) for OSA International Registry
Adherence and Outcome of Upper Airway Stimulation (UAS) for OSA International Registry
Enrollment Status: Active_not_recruiting
Publish Date: June 19, 2025
Intervention Type: Other, Device
A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy
A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy
Enrollment Status: Completed
Publish Date: January 13, 2025
Intervention Type: Drug
Study Drug: SUVN-G3031
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled, Multiple Rising Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-994 in Patients With Narcolepsy With or Without Cataplexy (Narcolepsy Type 1 or Narcolepsy Type 2)
A Randomized, Double-Blind, Placebo-Controlled, Multiple Rising Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-994 in Patients With Narcolepsy With or Without Cataplexy (Narcolepsy Type 1 or Narcolepsy Type 2)
Enrollment Status: Terminated
Publish Date: October 29, 2024
Intervention Type: Drug
Study Drug: TAK-994
Study Phase: Phase 2
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Evaluate the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Evaluate the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug
Study Phase: Phase 3
ImThera Medical Targeted Hypoglossal Neurostimulation Study #3
ImThera Medical Targeted Hypoglossal Neurostimulation Study #3
Enrollment Status: Completed
Publish Date: February 07, 2024
Intervention Type: Device
Study Phase: Not Applicable
A Dose-Blind Extension Study With Double-blind, Placebo-Controlled, Randomized Withdrawal Period to Evaluate the Safety and Explore the Pharmacokinetics and Pharmacodynamics of TAK-994 in Adults With Narcolepsy With Cataplexy (Narcolepsy Type 1)
A Dose-Blind Extension Study With Double-blind, Placebo-Controlled, Randomized Withdrawal Period to Evaluate the Safety and Explore the Pharmacokinetics and Pharmacodynamics of TAK-994 in Adults With Narcolepsy With Cataplexy (Narcolepsy Type 1)
Enrollment Status: Terminated
Publish Date: December 26, 2023
Intervention Type: Drug
Study Phase: Phase 2
A 6-Month Multicenter, Open-Labelled Extension of the Clinical Trial NLS-1021 in Narcoleptic Patients With and Without Cataplexy
A 6-Month Multicenter, Open-Labelled Extension of the Clinical Trial NLS-1021 in Narcoleptic Patients With and Without Cataplexy
Enrollment Status: Completed
Publish Date: March 13, 2023
Intervention Type: Drug
Study Drug: Mazindol
Study Phase: Phase 2
A Four-week, Double-blind, Placebo-controlled, Randomized, Multicenter, Parallel-group Study of the Safety and Efficacy of NLS-2 (Mazindol Extended Release) in Adults for the Treatment of Narcolepsy
A Four-week, Double-blind, Placebo-controlled, Randomized, Multicenter, Parallel-group Study of the Safety and Efficacy of NLS-2 (Mazindol Extended Release) in Adults for the Treatment of Narcolepsy
Enrollment Status: Completed
Publish Date: August 12, 2022
Intervention Type: Drug
Study Drug: Mazindol
Study Phase: Phase 2
A Study to Assess the Frequency and Characteristics of Wake and Sleep State Transitions Over Multiple Nights in Subjects With Narcolepsy Type 1 Compared With Healthy Subjects Using a Portable Electroencephalogram Device
A Study to Assess the Frequency and Characteristics of Wake and Sleep State Transitions Over Multiple Nights in Subjects With Narcolepsy Type 1 Compared With Healthy Subjects Using a Portable Electroencephalogram Device
Enrollment Status: Completed
Publish Date: May 07, 2021
Intervention Type: Device
A Double-Blind, Placebo-Controlled, Randomized-Withdrawal, Multicenter Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy
A Double-Blind, Placebo-Controlled, Randomized-Withdrawal, Multicenter Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy
Enrollment Status: Completed
Publish Date: November 12, 2020
Intervention Type: Drug, Other
Study Phase: Phase 3
View 10 Less Clinical Trials

9 Total Publications

RESTORE: Once-nightly oxybate dosing preference and nocturnal experience with twice-nightly oxybates.
RESTORE: Once-nightly oxybate dosing preference and nocturnal experience with twice-nightly oxybates.
Journal: Sleep medicine: X
Published: May 23, 2024
Similar Doctors
Expertise in
18
conditions
Dr. Karthikeyan Kanagarajan
Sleep Medicine | Pulmonary Medicine | Intensive Care Medicine
Expertise in
18
conditions
Dr. Karthikeyan Kanagarajan
Sleep Medicine | Pulmonary Medicine | Intensive Care Medicine

The Christ Hospital Medical Associates, LLC

11140 Montgomery Rd, 
Cincinnati, OH 
 (4.9 miles away)
513-561-7809
Languages Spoken:
English, Hindi, Tamil
See accepted insurances
Accepting New Patients

Karthikeyan Kanagarajan is a Sleep Medicine specialist and a Pulmonary Medicine provider in Cincinnati, Ohio. Dr. Kanagarajan is highly rated in 18 conditions, according to our data. His top areas of expertise are Drowsiness, Excessive Daytime Sleepiness, Obstructive Sleep Apnea, Sleep Paralysis, and Endoscopy. Dr. Kanagarajan is currently accepting new patients.

Expertise in
19
conditions
Dr. Sunil K. Dama
Sleep Medicine | Pulmonary Medicine | Intensive Care Medicine
Expertise in
19
conditions
Dr. Sunil K. Dama
Sleep Medicine | Pulmonary Medicine | Intensive Care Medicine

The Christ Hospital Medical Associates, LLC

2123 Auburn Ave, Suite 440, 
Cincinnati, OH 
 (9.3 miles away)
513-421-2600
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Sunil Dama is a Sleep Medicine specialist and a Pulmonary Medicine provider in Cincinnati, Ohio. Dr. Dama is highly rated in 19 conditions, according to our data. His top areas of expertise are Drowsiness, Excessive Daytime Sleepiness, Obstructive Sleep Apnea, Gastrostomy, and Endoscopy. Dr. Dama is currently accepting new patients.

Expertise in
11
conditions
Dr. Robert P. Baughman
Pulmonary Medicine | Intensive Care Medicine
Expertise in
11
conditions
Dr. Robert P. Baughman
Pulmonary Medicine | Intensive Care Medicine
222 Piedmont Ave, 
Cincinnati, OH 
 (8.4 miles away)
513-584-5224
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Robert Baughman is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Cincinnati, Ohio. Dr. Baughman is highly rated in 11 conditions, according to our data. His top areas of expertise are Sarcoidosis, Acute Interstitial Pneumonia, Neurosarcoidosis, Endoscopy, and Lung Transplant. Dr. Baughman is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Corser's expertise for a condition
ConditionClose
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile